BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    Implantable Pacemaker Pulse-Generator

    PMA: P980035 · Supplement: S032 · Decision Feb 20, 2004
    View on FDA
    Classifications
    1
    FEI Numbers
    28
    Registration Numbers
    28

    Basic Information

    Device Name
    Implantable Pacemaker Pulse-Generator
    Trade Name
    MEDTRONIC ENPULSE IMPLANTABLE PULSE GENERATOR AND MODEL 9991 APPLICATION SOFTWARE
    PMA Number
    P980035
    Supplement Number
    S032
    Device Class
    FDA Class 3
    Product Code
    DXY
    Generic Name
    implantable pacemaker Pulse-generator
    Regulation Number
    870.3610
    Medical Specialty
    Cardiovascular
    Advisory Committee
    Cardiovascular
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    February 20, 2004
    Date Received
    August 29, 2003
    Supplement Type
    Normal 180 Day Track
    Supplement Reason
    Change Design/Components/Specifications/Material
    Expedited Review
    N

    Advisory Committee Statement

    APPROVAL FOR THE ENPULSE IMPLANTABLE PULSE GENERATOR MODELS E2DR01, E2DR03, E2DR06, E2DR21, E2DR31, E2DR33, E2D01, E2D03, E2VDD01, E2SR01, E2SR03, E2SR06 WITH ATRIAL CAPTURE MANAGEMENT AND MODEL 9991 APPLICATION SOFTWARE. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME ENPULSE IPG AND IS INDICATED AS FOLLOWS: ENPULSE PACEMAKERS ARE INDICATED FOR USE IN PATIENTS WHO ARE EXPERIENCING ACCEPTED CONDITIONS WARRANTING CHRONIC CARDIAC PACING WHICH INCLUDE: 1) SYMPTOMATIC PAROXYSMAL OR PERMANENT SECOND OR THIRD-DEGREE AV BLOCK 2) SYMPTOMATIC BILATERAL BUNDLE BRANCH BLOCK 3) SYMPTOMATIC PAROXYSMAL OR TRANSIENT SINUS NODE DYSFUNCTIONS WITH OR WITHOUT ASSOCIATED AV CONDUCTION DISORDERS. 4) BRADYCARDIA-TACHYCARDIA SYNDROME 5) VASOVAGAL SYNDROMES OR HYPERSENSITITVE CAROTID SINUS SYNDROMES. ENPULSE PACEMAKERS ARE ALSO INDICATED FOR USE IN PATIENTS WHO MAY BENEFIT FROM RATE RESPONSIVE PACING TO SUPPORT CARDIAC OUTPUT DURING VARYING LEVELS OF ACTIVITY. USING RATE RESPONSE MODES MAY RESTORE HEART RATE VARIABILITY BY IMPROVING CARDIAC OUTPUT. THESE DEVICES ARE ALSO INDICATED FOR USE IN PATIENTS WHO MAY BENEFIT FROM MAINTENANCE OF AV SYNCHRONY THROUGH THE USE OF DUAL CHAMBER MODES AND ATRIAL TRACKING MODES. DUAL CHAMBER MODES ARE SPECIFICALLY INDICATED FOR TREATMENT OF CONDUCTION DISORDERS THAT REQUIRE RESTORATION OF BOTH RATE AND AV SYNCHRONY. DUAL CHAMBER MODES ARE INDICATED FOR USE IN PATIENTS WHO HAVE EXPERIENCED ONE OR BOTH OF THE FOLLOWING CONDITIONS. 1) VARIOUS DEGREES OF AV BLOCK 2) VVI INTOLERANCE (FOR EXAMPLE, PACEMAKER SYNDROME) IN PRESENCE OF PERSISTENT SINUS RHYTHM. THE DEVICE IS ALSO INDICATED FOR VDD PACING IN PATIENTS WHO HAVE ADEQUATE RATES AND ON OR BOTH OF THE FOLLOWING CONDITIONS. 1) A REQUIREMENT FOR VENTRICULAR PACING WHEN ADEQUATE ATRIAL RATES AND ADEQUATE INTRACAVITARY ATRIAL COMPLEXES ARE PRESENT. THIS INCLUDES THE PRESENCE OF COMPLETE AV BLOCK WHEN ATRIAL CONTRIBUTION IS NEEDED FOR HEMODYNAMIC BENEFIT OR WHEN...

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    DXY Implantable Pacemaker Pulse-Generator